// App-Quantinova.ai

5008 : The CADMUS trial: A paired cohort, blinded study comparing multiparametric ultrasound targeted biopsies with multiparametric MRI targeted biopsies in the detection of clinically significant prostate cancer.

Researchers

Presenter

  • Alistair Grey

Principal Investigators

  • Bina Shah

  • Peter Acher

  • Sidath Liyanage

  • Menelaos Pavlou

  • Rumana Omar

  • Frank Chinegwundoh

  • Prasad Patki

  • Diane Campbell

  • Taimur T. Shah

  • Sami Hamid

  • Chris Brew-Graves

  • Nim Arumainayagam

  • Alex Chapman

  • David Eldred-Evans

  • Alex Freeman

  • Mathias Winkler

  • Mark Emberton

  • Hashim Uddin Ahmed

Medical Centers

  • Kings College London, London, United Kingdom

  • Surgical and Interventional Trials Unit, University College London, London, United Kingdom

  • Southend University Hospital, Essex, United Kingdom

  • Department of Pathology, Southend University Hospital, Essex, United Kingdom

  • Kings College London, London, United Kingdom

  • Kings College London, London, United Kingdom

  • IMS Health, London, United Kingdom

  • Barts and The Royal London Hospital, London, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • Department of Colorectal Surgery, The Whittington Hospital, London, United Kingdom

  • Division of Medicine, University College London, London, United Kingdom

  • Department of Radiology, Ashford and St Peter's Hospitals, London, United Kingdom

  • Department of Radiology, Ashford and St Peter's Hospitals, London, United Kingdom

  • Imperial Prostate, London, United Kingdom

  • Imperial College, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Double Blind/Blinded

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A